Companies: 10,795·Total market cap: $144.5T
Select Medical Holdings Corporation

Select Medical Holdings Corporation

SEMNYSEHealthcare● Active
$16.54
+$0.05(+0.30%)
Market Cap$2.1B
P/E Ratio
52W High$16.99
52W Low$11.65
Overview

Select Medical Holdings Corporation (SEM) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

sem · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Hold

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
5
Hold
8
Sell
1
Strong Sell
0
Total: 14 · Buy rate: 35.7%

12-Month Price Target

High

$19.00

Consensus

$17.75

+7.3% upside

Low

$16.50

Median: $17.75 · Last Close: $16.54

The Select Medical Holdings Corporation (SEM) analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month SEM price target is $17.75, representing +7.3% upside from the current price of $16.54.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $18 (7.3%)

Consensus Target

$17.75

7.3% upside

High Target

$19

14.9%

Low Target

$16.5

-0.2%

Current Price

$16.54

as of today

Based on analyst price targets, the SEM stock price prediction for the next 12 months ranges from $16.5 to $19. The consensus SEM price forecast of $17.75 implies 7.3% upside from the current price of $16.54.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$16.530.06%

1-day model range: $16.53–$16.54. Peak: $16.54 (-0.06%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$17+2.7%
2028$17+4.4%
2029$17+5.4%
2030$18+6.0%
2031+6.4%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)58.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · SEM · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$16.50BUY
MA 10$16.51BUY
MA 20$16.49BUY
MA 50$16.43BUY
MA 100$16.05BUY
MA 200$14.93BUY
Current $SEM · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$16.51BUY
EMA 10$16.51BUY
EMA 20$16.49BUY
EMA 50$16.36BUY
EMA 100$16.01BUY
EMA 200$15.66BUY
Current $SEM · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Mizuho2026-05-13
Downgrade ↓
OutperformNeutral
Benchmark2026-03-04
Downgrade ↓
BuyHold
RBC Capital2026-03-03
Downgrade ↓
OutperformSector Perform
RBC Capital2026-02-23
Maintains
OutperformOutperform
RBC Capital2025-10-08
Maintains
OutperformOutperform
B of A Securities2025-09-10
Maintains
BuyBuy
UBS2025-08-04
Maintains
NeutralNeutral
RBC Capital2025-05-07
Maintains
OutperformOutperform
RBC Capital2025-02-24
Maintains
OutperformOutperform
UBS2025-01-03
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Select Medical Holdings Corporation (SEM) stock. Of the recent 90 rating actions, 7 were upgrades and 17 were downgrades. 14 analysts currently cover SEM.

Analyst Recommendation Trends

Buy ratings00
Hold ratings11
Sell ratings00

SEM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$6.8B

↑ 19.6% YoY

Revenue Next Year

$5.4B

↓ 20.4% YoY

EPS This Year

$1.45

EPS Next Year

$1.23

↓ 15.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SEM EPS of $1.45 for the current fiscal year, based on estimates from 2 analysts. The SEM revenue forecast is $6.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SEM stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SEM price target is $17.75 (+7.3% upside), with an analyst consensus of Hold.

The SEM short-term stock prediction for tomorrow is $16.53 (-0.06%). The SEM stock price prediction for 2027 estimates an average of $17. The SEM stock prediction for 2030 projects a range of $17–$18.

Select Medical Holdings Corporation trades on NYSE under the ticker SEM. The SEM stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 36% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

SEM forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month SEM price target is $17.75, with a high forecast of $19.00 and a low of $16.50. The median price target is shown in the chart above when available. This implies +7.3% potential upside from the current price of $16.54.

SEM price targetWhat is SEM price targetSEM analyst price targetSEM 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.